1. Home
  2. TENX vs ROC Comparison

TENX vs ROC Comparison

Compare TENX & ROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$1.83

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Logo Rank One Computing Corporation Common stock

ROC

Rank One Computing Corporation Common stock

N/A

Current Price

$4.05

Market Cap

78.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
ROC
Founded
1967
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
78.6M
IPO Year
2001
2025

Fundamental Metrics

Financial Performance
Metric
TENX
ROC
Price
$1.83
$4.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
★ $29.67
$9.00
AVG Volume (30 Days)
★ 3.9M
16.8K
Earning Date
05-15-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $16,979,679.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 23.90
52 Week Low
$1.31
$3.71
52 Week High
$19.40
$7.80

Technical Indicators

Market Signals
Indicator
TENX
ROC
Relative Strength Index (RSI) 27.10 41.16
Support Level $1.31 $3.71
Resistance Level $2.22 $4.59
Average True Range (ATR) 0.12 0.23
MACD 0.32 -0.01
Stochastic Oscillator 5.95 8.20

Price Performance

Historical Comparison
TENX
ROC

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ROC Rank One Computing Corporation Common stock

Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.

Share on Social Networks: